Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis
Hua Li, … , David G. Beer, Yi Sun
Hua Li, … , David G. Beer, Yi Sun
Published January 16, 2014
Citation Information: J Clin Invest. 2014;124(2):835-846. https://doi.org/10.1172/JCI70297.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 10

Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis

  • Text
  • PDF
Abstract

Cullin-RING ligases (CRLs) are a family of E3 ubiquitin ligase complexes that rely on either RING-box 1 (RBX1) or sensitive to apoptosis gene (SAG), also known as RBX2, for activity. RBX1 and SAG are both overexpressed in human lung cancer; however, their contribution to patient survival and lung tumorigenesis is unknown. Here, we report that overexpression of SAG, but not RBX1, correlates with poor patient prognosis and more advanced disease. We found that SAG is overexpressed in murine KrasG12D-driven lung tumors and that Sag deletion suppressed lung tumorigenesis and extended murine life span. Using cultured lung cancer cells, we showed that SAG knockdown suppressed growth and survival, inactivated both NF-κB and mTOR pathways, and resulted in accumulation of tumor suppressor substrates, including p21, p27, NOXA, and BIM. Importantly, growth suppression by SAG knockdown was partially rescued by simultaneous knockdown of p21 or the mTOR inhibitor DEPTOR. Treatment with MLN4924, a small molecule inhibitor of CRL E3s, also inhibited the formation of KrasG12D-induced lung tumors through a similar mechanism involving inactivation of NF-κB and mTOR and accumulation of tumor suppressor substrates. Together, our results demonstrate that Sag is a Kras-cooperating oncogene that promotes lung tumorigenesis and suggest that targeting SAG-CRL E3 ligases may be an effective therapeutic approach for Kras-driven lung cancers.

Authors

Hua Li, Mingjia Tan, Lijun Jia, Dongping Wei, Yongchao Zhao, Guoan Chen, Jie Xu, Lili Zhao, Dafydd Thomas, David G. Beer, Yi Sun

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2009 Total
Citations: 1 3 5 3 2 7 5 3 6 9 4 5 1 54
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (54)

Title and authors Publication Year
RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes
Tao Y, Shi Z, Liang X, Zheng Y, Dai L, Li X, Li Z, Liang W, Bai G, Li H, Lyu Y, Li J, Zhang T, Hu W, Zhou S, Shan Q, Fu X, Wang X
Molecular Carcinogenesis 2025
Protein neddylation and its role in health and diseases.
Zhang S, Yu Q, Li Z, Zhao Y, Sun Y
Signal Transduction and Targeted Therapy 2024
Sag deletion promotes DMBA/TPA‐induced skin carcinogenesis via YAP accumulation
Sun Y, Xu J, Wei D, Li H
MedComm 2024
高表达RNF7增强非小细胞肺癌细胞的PD-1耐药:基于活化NF-kB通路促进CXCL1表达和髓源性抑制细胞的募集
Journal of Southern Medical University 2024
The UBE2C-CDH1-DEPTOR axis is an oncogene-tumor suppressor cascade in lung cancer cells
Shizhen Zhang, Xiahong You, Yawen Zheng, Yanwen Shen, Xiufang Xiong, YI SUN
Journal of Clinical Investigation 2023
RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway
Hua H, Xie H, Zheng J, Lei L, Deng Z, Yu C
Oxidative medicine and cellular longevity 2023
Prognostic biomarkers and molecular pathways mediating Helicobacter pylori-induced gastric cancer: a network-biology approach.
Kamarehei F, Saidijam M, Taherkhani A
Genomics & Informatics 2023
Inactivation of Rbx1 E3 ligase suppresses KrasG12D ‐driven lung tumorigenesis
Li Y, Wu D, Li H, Sun Y
2023
The Functional Redundancy of Neddylation E2s and E3s in Modulating the Fitness of Regulatory T Cells
Wu D, Sun Y
Research 2023
The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness
D Wu, H Li, M Liu, J Qin, Y Sun
Nature Communications 2022
An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases
Huang T, Li J, Liu X, Shi B, Li S, An HX
Frontiers in immunology 2022
A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
Xu T, Ma Q, Li Y, Yu Q, Pan P, Zheng Y, Li Z, Xiong X, Hou T, Yu B, Liu H, Sun Y
Signal Transduction and Targeted Therapy 2022
Discovery of a small molecule inhibitor of cullin neddylation that triggers ER stress to induce autophagy
Y Li, C Wang, T Xu, P Pan, Q Yu, L Xu, X Xiong, T Hou, S Cui, Y Sun
Acta pharmaceutica Sinica. B 2021
A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
H Shoji, D Takahari, H Hara, K Nagashima, J Adachi, N Boku
Future Science OA 2021
Post-translational modification of KRAS: potential targets for cancer therapy
W Wang, T Yuan, M Qian, F Yan, L Yang, Q He, B Yang, J Lu, H Zhu
Acta Pharmacologica Sinica 2020
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer
H Zuo, L Chen, N Li, Q Song
Frontiers in Genetics 2020
Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells
X Zhou, S Han, K Wilder-Romans, GY Sun, H Zhu, X Liu, M Tan, G Wang, FY Feng, Y Sun
Neoplasia (New York, N.Y.) 2020
Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras–PDAC model
Q Zhang, D Wei, M Tan, H Li, MA Morgan, Y Sun
Neoplasia (New York, N.Y.) 2020
Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment
UI Ju, DW Jeong, J Seo, JB Park, JW Park, KS Suh, JB Kim, YS Chun
Cell Death and Disease 2020
The Negative Cross-Talk between SAG/RBX2/ROC2 and APC/C E3 Ligases in Regulation of Cell Cycle Progression and Drug Resistance
S Zhang, Y Shen, H Li, C Bi, Y Sun, X Xiong, W Wei, Y Sun
Cell Reports 2020
SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer
A Liu, S Zhang, W Li, B Xu, R Lei, S Zhu
Aging 2020
Neddylation: a novel modulator of the tumor microenvironment
L Zhou, Y Jiang, Q Luo, L Li, L Jia
Molecular Cancer 2019
Kindlin-2 links mechano-environment to proline synthesis and tumor growth
L Guo, C Cui, K Zhang, J Wang, Y Wang, Y Lu, K Chen, J Yuan, G Xiao, B Tang, Y Sun, C Wu
Nature Communications 2019
Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib
Z Yang, J Zhang, X Lin, D Wu, G Li, C Zhong, L Fang, P Jiang, L Yin, L Zhang, P Bie, CM Xie
Oncology reports 2019
Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM
Y Wang, M Tan, H Li, H Li, Y Sun
Translational oncology 2019
The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells
Y Yin, CM Xie, H Li, M Tan, G Chen, R Schiff, X Xiong, Y Sun
Proceedings of the National Academy of Sciences 2019
Protein neddylation and its alterations in human cancers for targeted therapy
L Zhou, W Zhang, Y Sun, L Jia
Cellular Signalling 2018
SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets
X Xiong, ND Mathewson, H Li, M Tan, H Fujiwara, H Li, P Reddy, Y Sun
Frontiers in immunology 2018
DEPTOR at the Nexus of Cancer, Metabolism, and Immunity
A Caron, DM Briscoe, D Richard, M Laplante
Physiological reviews 2018
The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor
J Xu, W Zhou, F Yang, G Chen, H Li, Y Zhao, P Liu, H Li, M Tan, X Xiong, Y Sun
Nature Communications 2017
RNF7 knockdown inhibits prostate cancer tumorigenesis by inactivation of ERK1/2 pathway
Y Xiao, Y Jiang, H Song, T Liang, Y Li, D Yan, Q Fu, Z Li
Scientific Reports 2017
MLN4924 neddylation inhibitor promotes cell death in paclitaxel‑resistant human lung adenocarcinoma cells
Q Xu, G Lin, H Xu, L Hu, Y Wang, S Du, W Deng, W Hu, W Cheng, K Jiang
Oncology Letters 2017
DNA Replication
H Masai, M Foiani
2017
The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors
V Vanderdys, A Allak, F Guessous, M Benamar, PW Read, MJ Jameson, T Abbas
Molecular cancer therapeutics 2017
Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia
S Zheng, GM Leclerc, B Li, RT Swords, JC Barredo
Oncotarget 2017
The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR
L Zhou, S Chen, Y Zhang, M Kmieciak, Y Leng, L Li, H Lin, KA Rizzo, CI Dumur, A Ferreira-Gonzalez, M Rahmani, L Povirk, S Chalasani, AJ Berger, Y Dai, S Grant
Blood 2016
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells
H Lan, Z Tang, H Jin, Y Sun
Scientific Reports 2016
Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo
X Zhou, M Tan, MK Nyati, Y Zhao, G Wang, Y Sun
Proceedings of the National Academy of Sciences 2016
Neddylation E2 UBE2F promotes the survival of lung cancer cells by activating CRL5 to degrade NOXA via the K11 linkage
W Zhou, J Xu, H Li, M Xu, ZJ Chen, W Wei, ZQ Pan, Y Sun
Clinical cancer research 2016
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma
M Benamar, F Guessous, K Du, P Corbett, J Obeid, D Gioeli, CL Slingluff, T Abbas
EBioMedicine 2016
SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses
ND Mathewson, H Fujiwara, SR Wu, T Toubai, K Oravecz-Wilson, Y Sun, C Rossi, C Zajac, Y Sun, P Reddy
The American Journal of Pathology 2016
Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway
W Wang, H Chen, Z Liu, P Qu, J Lan, H Chen, L Zou, J Qiu
British Journal of Cancer 2016
SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation
P Kuang, M Tan, W Zhou, Q Zhang, Y Sun
Scientific Reports 2016
Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis
M Tan, J Xu, J Siddiqui, F Feng, Y Sun
Molecular Cancer 2016
Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization
M Tan, H Li, Y Sun
Neoplasia (New York, N.Y.) 2015
Regulation of the DNA damage response by ubiquitin conjugation
K Brinkmann, M Schell, T Hoppe, H Kashkar
Frontiers in Genetics 2015
Erbin is a novel substrate of the Sag- TrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis
CM Xie, D Wei, L Zhao, S Marchetto, L Mei, JP Borg, Y Sun
The Journal of Cell Biology 2015
A unified Bayesian semiparametric approach to assess discrimination ability in survival analysis: LDDP Mixture Model
L Zhao, D Feng, G Chen, JM Taylor
Biometrics 2015
Ubiquitination by SAG regulates macrophage survival/death and immune response during infection
SC Chang, JL Ding
Cell Death and Differentiation 2014
SCF ubiquitin ligase-targeted therapies
JR Skaar, JK Pagan, M Pagano
Nature Reviews Drug Discovery 2014
The Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor Suppressor RhoB for Degradation in Liver Cancer
J Xu, L Li, G Yu, W Ying, Q Gao, W Zhang, X Li, C Ding, Y Jiang, D Wei, S Duan, Q Lei, P Li, T Shi, X Qian, J Qin, L Jia
Molecular & cellular proteomics : MCP 2014
SAG/RBX2 is a novel substrate of NEDD4-1 E3 ubiquitin ligase and mediates NEDD4-1 induced chemosensitization
Zhou W, Xu J, Zhao Y, Sun Y
Oncotarget 2014
DEPTOR has growth suppression activity against pancreatic cancer cells
Li H, Sun GY, Zhao Y, Thomas D, Greenson JK, Zalupski MM, Ben-Josef E, Sun Y
Oncotarget 2014
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
45 readers on Mendeley
See more details